Beyond TG‑43: A PRISMA-based systematic review on model-based dose-calculation algorithms in brachytherapy
Abstract
Background and purpose: The AAPM TG-43 formalism has long served as the clinical standard for brachytherapy dose calculation but assumes a homogeneous water equivalent medium, overlooking limited scattering conditions and tissue heterogeneities. Model-based dose-calculation algorithms (MBDCAs), including Monte Carlo (MC) simulations overcome these limitations by accounting for real tissue composition, scatter, and applicator attenuation. This systematic review evaluates TG-43, MBDCAs/MC methods in terms of dosimetric accuracy, validation strategies, computational feasibility, clinical implementation barriers, and emerging innovations.
Methods: A PRISMA-guided literature search was conducted using the Scopus database, identifying 284 records, of which 42 full-text studies met inclusion criteria. Eligible studies compared at least two of the three dose-calculation approaches (TG-43, MBDCAs and MCs) in pelvic, breast, or head-and-neck brachytherapy. Extracted data encompassed dosimetric discrepancies, validation approaches, computational performance, workflow integration, and enabling technologies.
Results: Across anatomical sites, TG‑43 showed no consistent bias. Its differences from heterogeneity‑aware models depended on tissue composition, scatter conditions, and source geometry. In soft‑tissue regions with minimal heterogeneity, TG‑43 generally overestimated target coverage by about 0.5%-5%. Near low‑density interfaces or in reduced‑scatter configurations, TG‑43 could…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.